TAUNS LaboratoriesInc Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 4/6
TAUNS LaboratoriesInc has been growing earnings at an average annual rate of 90.3%, while the Medical Equipment industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 17.6% per year. TAUNS LaboratoriesInc's return on equity is 42.2%, and it has net margins of 31.3%.
Key information
90.3%
Earnings growth rate
90.3%
EPS growth rate
| Medical Equipment Industry Growth | 7.8% |
| Revenue growth rate | 17.6% |
| Return on equity | 42.2% |
| Net Margin | 31.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How TAUNS LaboratoriesInc makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 18,435 | 5,774 | 4,045 | 0 |
| 30 Jun 23 | 15,673 | 3,035 | 3,819 | 0 |
Quality Earnings: 197A has high quality earnings.
Growing Profit Margin: 197A's current net profit margins (31.3%) are higher than last year (19.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if 197A's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare 197A's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: 197A earnings growth over the past year (90.3%) exceeded the Medical Equipment industry 5.6%.
Return on Equity
High ROE: 197A's Return on Equity (42.2%) is considered outstanding.